We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.
TODAY'S HIGH
750
TODAY'S LOW
714.95
52 WEEK HIGH
1165
52 WEEK LOW
685.6
% of Shares Held by
All Insider
72.71%
% of Shares Held by
Institutions
15.58%
% of Float Held by
Institutions
57.08%
Number of Institutions
Holding Shares
27
MARKET CAP
6904.82 Cr.
ETERPRISE VALUE
6727.51 Cr.
NO. OF SHARES
9.59 Cr.
BOOK VALUE
106.21
DIV. YIELD
2.5%
DEBT
136.12 Cr.
GROSS PROFIT
522.89 Cr.
CASH
403.85 Cr.
REVENUE
878.54 Cr.
REVENUE/SHARE
92.648
Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
---|---|---|---|---|
Investments | -344.42 Cr. | -6.81 Cr. | -28.26 Cr. | -8.29 Cr. |
Change To Liabilities | 5.95 Lakhs | 10.20 Cr. | 13.68 Cr. | 1.66 Cr. |
Total cashflows from Investing Activities | -435.58 Cr. | -107.25 Cr. | -100.73 Cr. | -88.03 Cr. |
Net Borrowings | -67.59 Cr. | 31.93 Cr. | 28.24 Cr. | 30.93 Cr. |
Total Cash from Financing Activities | 316.94 Cr. | -20.50 Cr. | -5.12 Cr. | 15.71 Cr. |
Other Liabilities | -12.99 Cr. | 13.03 Lakhs | 7.57 Cr. | -12.83 Cr. |
Total Assets | 400 Cr. | 5.03 Lakhs | 5.03 Lakhs | 5.03 Lakhs |
Net Income | 135.87 Cr. | 95.87 Cr. | 65.39 Cr. | 70.59 Cr. |
Change in Cash | 9.72 Lakhs | 53.98 Lakhs | 61.68 Lakhs | 2.63 Cr. |
Effect of Exchange Rate | 0 | 0 | 0 | 0 |
Total Cash from Operating Activities | 118.73 Cr. | 128.30 Cr. | 106.48 Cr. | 74.95 Cr. |
Depreciation | 46.59 Cr. | 39.61 Cr. | 36.44 Cr. | 28.34 Cr. |
Other Cashflows from Investing Activities | 3.36 Cr. | 5.24 Cr. | 3.11 Cr. | 2.47 Cr. |
Dividends Paid | 0 | -42.47 Cr. | -21.19 Cr. | -4.41 Cr. |
Change to Inventory | -14.38 Cr. | -28.30 Cr. | -10.80 Cr. | -11.04 Cr. |
Change to Account Receivables | -33.86 Cr. | 5.89 Cr. | -19.15 Cr. | -15.13 Cr. |
Other Cashflows from Financing Activities | -15.45 Cr. | -10.01 Cr. | -12.22 Cr. | -10.80 Cr. |
Change to Net Income | -3.79 Cr. | 3.69 Cr. | 12.33 Cr. | 12.41 Cr. |
Capital Expenditures | -95.13 Cr. | -106.02 Cr. | -77.99 Cr. | -82.45 Cr. |
Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
---|---|---|---|---|
Research Development | 13.14 Cr. | 11.94 Cr. | 10.14 Cr. | 10.04 Cr. |
Effect of Accounting Charges | None | None | None | None |
Income Before Tax | 180.05 Cr. | 125.72 Cr. | 100.07 Cr. | 96.75 Cr. |
Minority Interest | 0 | 0 | 0 | -26 k |
Net Income | 166.85 Cr. | 123.97 Cr. | 93.69 Cr. | 91.16 Cr. |
Selling General Administrative | 144.77 Cr. | 143.14 Cr. | 122.43 Cr. | 103.54 Cr. |
Gross Profit | 522.89 Cr. | 468 Cr. | 400.17 Cr. | 353.74 Cr. |
Ebit | 166.85 Cr. | 123.97 Cr. | 93.69 Cr. | 91.16 Cr. |
Operating Income | 166.85 Cr. | 123.97 Cr. | 93.69 Cr. | 91.16 Cr. |
Other Operating Expenses | 150.59 Cr. | 148.42 Cr. | 136.59 Cr. | 119.74 Cr. |
Interest Expense | -6.98 Cr. | -9.89 Cr. | -11.96 Cr. | -9.80 Cr. |
Extraordinary Items | None | None | None | None |
Non Recurring | None | None | None | None |
Other Items | None | None | None | None |
Income Tax Expense | 44.17 Cr. | 29.84 Cr. | 34.67 Cr. | 26.15 Cr. |
Total Revenue | 786.46 Cr. | 687.23 Cr. | 610.82 Cr. | 520.41 Cr. |
Total Operating Expenses | 619.61 Cr. | 563.26 Cr. | 517.13 Cr. | 429.25 Cr. |
Cost of Revenue | 263.57 Cr. | 219.23 Cr. | 210.65 Cr. | 166.66 Cr. |
Total Other Income Expense Net | 13.19 Cr. | 1.75 Cr. | 6.37 Cr. | 5.58 Cr. |
Discontinued Operations | None | None | None | None |
Net Income from Continuous Ops. | 135.87 Cr. | 95.87 Cr. | 65.39 Cr. | 70.59 Cr. |
Net Income Applicable to Common Shares | 135.87 Cr. | 95.87 Cr. | 65.39 Cr. | 70.59 Cr. |
Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
---|---|---|---|---|
Intangible Assets | 22.82 Cr. | 23.41 Cr. | 23.56 Cr. | 21.73 Cr. |
Capital Surplus | 391.33 Cr. | 69.34 Lakhs | 34.67 Lakhs | 0 |
Total Liabilities | 258.16 Cr. | 332.50 Cr. | 272.58 Cr. | 226.52 Cr. |
Stock Holder Equity | 965.57 Cr. | 434.82 Cr. | 381.37 Cr. | 338.29 Cr. |
Minority Interest | 0 | 0 | 0 | -26 k |
Other Liabilities | 8.24 Cr. | 16.72 Cr. | 8.53 Cr. | 7.32 Cr. |
Total Assets | 1223.73 Cr. | 767.32 Cr. | 653.95 Cr. | 564.82 Cr. |
Common Stock | 47.94 Cr. | 44.12 Cr. | 44.11 Cr. | 44.11 Cr. |
Retained Earnings | 515.51 Cr. | 381.33 Cr. | 328.62 Cr. | 286.05 Cr. |
Other Liabilities | 21.52 Cr. | 21.53 Cr. | 27.60 Cr. | 24.83 Cr. |
Good Will | 28.58 Cr. | 28.58 Cr. | 28.58 Cr. | 0 |
Treasury Stock | 10.77 Cr. | 8.66 Cr. | 8.27 Cr. | 8.13 Cr. |
Other Assets | 24.66 Cr. | 39.95 Cr. | 20.90 Cr. | 21.55 Cr. |
Cash | 4.95 Cr. | 4.85 Cr. | 4.31 Cr. | 3.70 Cr. |
Current Liabilities | 171.39 Cr. | 193.27 Cr. | 153.59 Cr. | 122.57 Cr. |
Long Term Asset Charges | 0 | 0 | 0 | 0 |
Short Long Term Debt | 32.03 Cr. | 34.70 Cr. | 23.86 Cr. | 21.51 Cr. |
Other Stockholder Equity | 10.77 Cr. | 8.66 Cr. | 8.27 Cr. | 8.13 Cr. |
Property Plant Equipment | 391.01 Cr. | 332.20 Cr. | 270.01 Cr. | 258.30 Cr. |
Total Cur. Assets | 705.78 Cr. | 317.78 Cr. | 301.67 Cr. | 255.20 Cr. |
Long Term Investments | 50.85 Cr. | 25.38 Cr. | 9.21 Cr. | 8.02 Cr. |
Net Tangible Assets | 914.16 Cr. | 382.82 Cr. | 329.22 Cr. | 316.56 Cr. |
Short Term Investments | 24.30 Cr. | 20.19 Cr. | 50.05 Cr. | 16.54 Cr. |
Net Receivables | 175.25 Cr. | 137.22 Cr. | 147.69 Cr. | 133.54 Cr. |
Long Term Debt | 63.27 Cr. | 114.41 Cr. | 91.37 Cr. | 79.11 Cr. |
Inventory | 126.48 Cr. | 112.09 Cr. | 83.79 Cr. | 72.98 Cr. |
Accounts Payable | 64.52 Cr. | 66.36 Cr. | 55.53 Cr. | 43.62 Cr. |